Elutia Inc stock is traded at $0.9329, with a volume of 298,463. It is up +11.60% in the last 24 hours and up +13.34% over the past month. Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.
Previous Close:
$0.8359
Open:
$0.83
24h Volume:
298,463
Relative Volume:
3.46
Market Cap:
$41.32M
Revenue:
$15.97M
Net Income/Loss:
-$24.40M
P/E Ratio:
-
EPS:
-$0.7585
Net Cash Flow:
-$45.82M
1W Performance:
+22.81%
1M Performance:
+13.34%
6M Performance:
-11.99%
1Y Performance:
+13.24%
1-Day Range:
$0.82$0.95
1-Week Range:
$0.7036$0.95
52-Week Range:
$0.5$1.39
Elutia Inc Stock (ELUT) Company Profile
Name
Elutia IncSector
HealthcareIndustry
Medical DevicesPhone
240-247-1143Address
12510 PROSPERITY DRIVE, SILVER SPRING, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS